Product Information
DEXMETHYLPHENIDATE 2.5 MG TAB is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1900 per EA under NDC 67877065501. Its NADAC has been published 223 times since Jun 29, 2022.
FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877065501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212631FDA Approved
7/19/2019
TE Code
AB
On Market Since
7/21/2019
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE 2.5 MG TAB has been published 223 times since Jun 29, 2022, and over the history we have for it it has risen 38.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1900 per EA |
|---|---|
| All-time high | $0.2175 (Apr 15, 2026) |
| All-time low | $0.0914 (Dec 21, 2022) |
| 52-week high | $0.2175 |
| 52-week low | $0.1859 |
| Median price | $0.1832 |
| Average price | $0.1655 |
| Largest weekly change | +67.3% (Oct 18, 2023) |
| Weeks tracked | 223 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexmethylphenidate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE 2.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE 2.5 MG TAB, manufactured by Ascend Laboratories, LLC, is $0.1900 per EA (NDC 67877065501), effective Sep 30, 2026.
How has the price of DEXMETHYLPHENIDATE 2.5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE 2.5 MG TAB has risen 38.5%. It has been tracked across 223 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE 2.5 MG TAB?
Since Jun 29, 2022, the NADAC for DEXMETHYLPHENIDATE 2.5 MG TAB has ranged from a low of $0.0914 (Dec 21, 2022) to a high of $0.2175 (Apr 15, 2026), with a median of $0.1832 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE 2.5 MG TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXMETHYLPHENIDATE 2.5 MG TAB, is $0.1372 per EA — about 28% below DEXMETHYLPHENIDATE 2.5 MG TAB.
Who manufactures DEXMETHYLPHENIDATE 2.5 MG TAB?
DEXMETHYLPHENIDATE 2.5 MG TAB (NDC 67877065501) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.